Lenz Therapeutics stock rises after FDA approves presbyopia eye drops

Go back to Lenz Therapeutics stock rises after FDA approves presbyopia eye drops
(NASDAQ: LENZ) Delayed: 5.80 +0.57 (10.90%)
Previous Close $5.23    52 Week High
Open $5.21    52 Week Low
Day High $5.81    P/E N/A 
Day Low $5.21    EPS
Volume 993,229